AVO.L Share News (AVO)
AVO Share
AVO Share
AVO Share
AVO Share
AVO
AVO Share
AVO Broker
AVO Directors
AVO Financial
AVO
AVO Short
AVOThu, 17th Dec 2015 10:08
LONDON (Alliance News) - Advanced Oncotherapy PLC Thursday said Non-Executive Director Michael Bradfield bought 750,000 shares at a price of 5.5 pence per share Wednesday.
Following this transaction, Bradfield now holds 122.8 million shares, which represents 8.66% of the issued share capital.
Shares in the medical technology company were up 4.2% at 5.60p Thursday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
(ShareCast News) - Advanced Oncotherapy said two of its modules were ready for high power testing. The AIM listed proton therapy cancer treatment developer's shares fell by 3.33% to 7.25p by 1208 BST. Two of its Coupled Cavity Linac modules are now ready for high-power testing at the company's fac
Read more(ShareCast News) - Advanced Oncotherapy said its partner in the Chinese market, Sinophi Healthcare, recently signed a framework agreement with China-Japan Union Hospital of Jilin University regarding a proton therapy centre. The company, which develops next-generation proton therapy systems for canc
Read more